Induction chemotherapy before surgery for unresectable head and neck cancer.
Fiche publication
Date publication
janvier 2016
Journal
B-ENT
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOREL Christian, Pr DEBRY Christian
Tous les auteurs :
Schmaltz H, Borel C, Ciftci S, Takeda-Raguin C, Debry C, Schultz P, Dupret-Bories A
Lien Pubmed
Résumé
To preoperatively reduce tumour size in patients with locally advanced and/or non-resectable squamous cell carcinoma with induction chemotherapy in order to achieve surgical excision with clear margins and preserve quality of life.
Mots clés
Adult, Antineoplastic Combined Chemotherapy Protocols, administration & dosage, Carboplatin, administration & dosage, Carcinoma, Squamous Cell, drug therapy, Cetuximab, administration & dosage, Cisplatin, administration & dosage, Cohort Studies, Disease-Free Survival, Female, Fluorouracil, administration & dosage, Head and Neck Neoplasms, drug therapy, Humans, Induction Chemotherapy, methods, Male, Middle Aged, Mouth Neoplasms, drug therapy, Oropharyngeal Neoplasms, drug therapy, Paclitaxel, administration & dosage, Retrospective Studies, Taxoids, administration & dosage, Treatment Outcome
Référence
B-ENT. 2016 ;12(1):29-32